These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. New safety information on Ketek. FDA Consum; 2006; 40(5):8. PubMed ID: 17328103 [No Abstract] [Full Text] [Related]
24. Telithromycin-induced TEN: report of a case. Bédard MS; Gilbert M Arch Dermatol; 2007 Mar; 143(3):427-8. PubMed ID: 17372117 [No Abstract] [Full Text] [Related]
25. Effective integration of medical and pharmacy claims to better protect patient safety--a long road yet to travel. Curtiss FR J Manag Care Pharm; 2007 Jun; 13(5):429-30. PubMed ID: 17605515 [No Abstract] [Full Text] [Related]
26. Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety. Mathews AW Wall St J (East Ed); 2006 May; ():A1, A12. PubMed ID: 16838449 [No Abstract] [Full Text] [Related]
27. Telithromycin. Turner M; Corey GR; Abrutyn E Ann Intern Med; 2006 Mar; 144(6):447-8. PubMed ID: 16549859 [No Abstract] [Full Text] [Related]
28. Severe hepatotoxicity of telithromycin. Bertino JS Ann Intern Med; 2006 Sep; 145(6):472; author reply 472. PubMed ID: 16983140 [No Abstract] [Full Text] [Related]
32. [Problems in the administration of antibiotics to the patients with myasthenia gravis]. Onishi A; Shida K; Kuroiwa Y Naika; 1970 Nov; 26(5):926-9. PubMed ID: 5529430 [No Abstract] [Full Text] [Related]
33. Levofloxacin-induced myasthenic crisis. Gutiérrez-Gutiérrez G; Sereno M; García Vaquero C; Miralles A J Emerg Med; 2013 Aug; 45(2):260-1. PubMed ID: 23218195 [No Abstract] [Full Text] [Related]
34. Summaries for patients. Telithromycin: a possible cause of severe liver damage? Ann Intern Med; 2006 Mar; 144(6):I42. PubMed ID: 16481450 [No Abstract] [Full Text] [Related]
35. You're the flight surgeon. Myasthenia gravis. Guliuzza RJ Aviat Space Environ Med; 2005 Apr; 76(4):406-7. PubMed ID: 15828645 [No Abstract] [Full Text] [Related]
40. [Influence of a regulatory safety warning on the use of telithromycin]. Carracedo Martínez E; Pía-Morandeira A Med Clin (Barc); 2011 Apr; 136(10):456-7. PubMed ID: 19819480 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]